Gangliosides reduce the development of ethanol dependence without affecting ethanol tolerance

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 1, 1996, Pages 128-136

  Snell, Lawrence D ^a,b   Szabó, Gyula ^b   Tabakoff, Boris ^a,b,c   Hoffman, Paula L ^a,b  

^a Lohocla Research Corporation   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE; GANGLIOSIDE GD 1A; GANGLIOSIDE GD 1B; GANGLIOSIDE GM1; GANGLIOSIDE GT 1B;

ALCOHOL CONSUMPTION; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANIMAL BEHAVIOR; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG TOLERANCE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BRAIN; CALCIUM CHANNELS; CATTLE; DRUG TOLERANCE; ETHANOL; GANGLIOSIDES; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, N-METHYL-D-ASPARTATE; SUBSTANCE-RELATED DISORDERS;

EID: 0030426907     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. AHERN, K. V., LUSTIG, H. S. AND GREENBERG, D. A.: Enhancement of NMDA toxicity and calcium responses by chronic exposure of cultured cortical neurons to ethanol. Neurosci. Lett. 165: 211-214, 1994.
2. 1 monosialoganglioside in the rat. Clin. Trials J. 26: 39-48, 1989.
3. CARTER, L. A., BELKNAP, J. K., CRABBE, J. C. AND JANOWSKY, A.: Allosteric regulation of the N-methyl-D-aspartate receptor-linked ion channel complex and effects of ethanol in ethanol-withdrawal seizure-prone and -resistant mice. J. Neurochem. 64: 213-219, 1995.
4. CHANDLER, L. J., NEWSOM, H., SUMNERS, C. AND CREWS, F.: Chronic ethanol exposure potentiates NMDA excitotoxicity in cerebral cortical neurons. J. Neurochem. 60: 1578-1581, 1993.
5. CHARNESS, M. E.: Brain lesions in alcoholics. Alcohol. Clin. Exp. Res. 17: 2-11, 1993.
6. CHEN, L. AND HUANG, L.-Y. M.: Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a mu opioid. Neuron 7: 319-326, 1991.
7. CRABBE, J. C. AND KOSOBUD, A.: Sensitivity and tolerance to ethanol in mice bred to be genetically prone or resistant to ethanol. J. Pharmacol. Exp. Ther. 239: 327-333, 1986.
8. 2+ channels in rat brain may underlie ethanol physical dependence. Neuropharmacology 26: 275-279, 1987.
9. DOLIN, S. J. AND LITTLE, H. J.: Are changes in neuronal calcium channels involved in ethanol tolerance? J. Pharmacol. Exp. Ther. 250: 985-991, 1989.
10. GHIDONI, R., FIORELLI, A., TRINCHERA, M., VENERANDO, B., CHIGORNO, V. AND TETTAMANTI, G.: Uptake, cell penetration and metabolic processing of exogenously administered GM1 ganglioside in rat brain. Neurochem. Int. 15: 455-465, 1989.
11. GOLDSTEIN, A. AND GOLDSTEIN, D. B.: Enzyme expansion theory of drug tolerance and physical dependence. Res. Publ. Assoc. Res. Nerv. Ment. Dis. 46: 265-267, 1968.
12. GRANT, K. A., SNELL, L. D., ROGAWSKI, M. A., THURKAUF, A. AND TABAKOFF, B.: Comparison of the effects of the uncompetitive N-methyl-d-aspartate antagonist (±)-5-aminocarbonyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (ADCI) with its structural analogs dizocilpine (MK-801) and carbamazepine on ethanol withdrawal seizures. J. Pharmacol. Exp. Ther. 260: 1017-1022, 1992.
13. GRANT, K. A., VALVERIUS, P., HUDSPITH, M. AND TABAKOFF, B.: Ethanol withdrawal seizures and the NMDA receptor complex. Eur. J. Pharmacol. 176: 289-296, 1990.
14. GULYA, K., GRANT, K. A., VALVERIUS, P., HOFFMAN, P. L. AND TABAKOFF, B.: Brain regional specificity and time course of changes in the NMDA receptor-ionophore complex during ethanol withdrawal. Brain Res. 547: 129-134, 1991.
15. HARRIS, R. A., GROH, G. I., BAXTER, D. M. AND HITZEMANN, R. J.: Gangliosides enhance the membrane actions of ethanol and pentobarbital. Mol. Pharmacol. 25: 410-417, 1984.
16. 1. Alcohol. Clin. Exp. Res. 19: 721-726, 1995.
17. HU, X.-J. AND TICKU, M. K.: Chronic ethanol treatment upregulates the NMDA receptor function and binding in mammalian cortical neurons. Mol. Brain Res. 30: 347-356, 1995.
18. HUNG, C. R., TABAKOFF, B., MELCHIOR, C. L. AND HOFFMAN, P. L.: Intraventricular arginine vasopressin maintains ethanol tolerance. Eur. J. Pharmacol. 106: 645-648, 1984.
19. +-ATPase. Drug Dev. Res. 19: 443-451, 1990.
20. IORIO, K. R., REINLIB, L., TABAKOFF, B. AND HOFPMAN, P. L.: Chronic exposure of cerebellar granule cells to ethanol results in increased N-methyl-d-aspartate receptor function. Mol. Pharmacol. 41: 1142-1148, 1992.
21. IORIO, K. R., TABAKOFF, B. AND HOFFMAN, P. L.: Glutamate-induced neurotoxicity is increased in cerebellar granule cells exposed chronically to ethanol. Eur. J. Pharmacol. Environ. Toxicol. 248: 209-212, 1993.
22. JOHNSON, S. M. AND FLEMING, W. W.: Mechanisms of cellular adaptive sensitivity changes: Applications to opioid tolerance and dependence. Pharmacol. Rev. 41: 435-487, 1989.
23. KELSO, S. R., NELSON, T. E. AND LEONARD, J. P.: Protein kinase C-mediated enhancement of NMDA currents by metabotropic glutamate receptors in Xenopus oocytes. J. Physiol. (Lond.) 449: 705-718, 1992.
24. KLEMM, W. R., BOYLES, R., MATHEW, J. AND CHERIAN, L.: Gangliosides, or sialic acid, antagonize ethanol intoxication. Life Sci. 43: 1837-1843, 1988.
25. LAEV, H., MAHADIK, S. P., BONHEUR, J. L., HERNANDEZ, N. AND KARPIAK, S. E.: GM1 ganglioside reduces glutamate toxicity to cortical cells. Mol. Chem. Neuropathol. 20: 229-243, 1993.
26. 3H-labeled exogenous gangliosides injected intramuscularly into rats. In Gangliosides in Neurological and Neuromuscular Function, Development, and Repair, ed. by M. M. Rapport and A. Gorio, pp. 241-251, Raven Press, New York, 1981.
27. LEDEEN, R. W. AND YU, R. K.: Gangliosides of the nervous system. In Ganglioside Methodology, pp. 187-214, American Oil Chemists Society, Champaign, IL, 1976.
28. LILJEQUIST, S.: The competitive NMDA receptor antagonist, CGP 39551, inhibits ethanol withdrawal seizures. Eur. J. Pharmacol. 192: 197-198, 1991.
29. LIPARTITI, M., LAZZARO, A. AND MANEV, H.: Ganglioside derivative LIGA20 reduces NMDA neurotoxicity in neonatal rat brain. NeuroReport 3: 919-921, 1992.
30. LITTLE, H. J., DOLIN, S. J. AND HALSEY, M. J.: Calcium channel antagonists decrease the ethanol withdrawal syndrome. Life Sci. 39: 2059-2065, 1988a.
31. LITTLE, H. J., DOUN, S. J. AND WHITTINGTON, M. A.: Possible role of calcium channels in ethanol tolerance and dependence. Ann. N.Y. Acad. Sci. 560: 465-466, 1988b.
32. LUCCHI, L., GOVONI, S., BATTAINI, F., PASINETTI, G. AND TRABUCCHI, M.: Ethanol administration in vivo alters calcium ions control in rat striatum. Brain Res. 332: 376-379, 1985.
33. MARKRAM, H. AND SEGAL, M.: Activation of protein kinase C suppresses responses to NMDA in rat CA1 hippocampal neurones. J. Physiol. (Lond.) 457: 491-501, 1992.
34. MAYER, D. J., MAO, J. AND PRICE, D. D.: The development of morphine tolerance and dependence is associated with translocation of protein kinase C. Pain 61: 365-374, 1995.
35. MORRISETT, R. A., REZVANI, A. H., OVERSTREET, D., JANOWSKY, D. S., WILSON, W. A. AND SWARTZWELDER, H. S.: MK-801 potently inhibits alcohol withdrawal seizures in rats. Eur. J. Pharmacol. 176: 103-105, 1990.
36. MUNSON, P. J. AND RODBARD, D.: LIGAND: A versatile computerized approach for the characterization of ligand binding systems. Anal. Biochem. 107: 220-239, 1980.
37. OGURA, K. AND HANDA, S.: Metabolism of exogenous gangliosides GM1 and chemically modified GM1 in mice. J. Biochem. (Tokyo) 104: 87-92, 1988.
38. RIAZ, A. AND FAINGOLD, C. L.: Seizures during ethanol withdrawal are blocked by focal microinjection of excitant amino acid antagonists into the inferior colliculus and pontine reticular formation. Alcohol. Clin. Exp. Res. 18: 1456-1462, 1994.
39. RITZMANN, R. F. AND TABAKOFF, B.: Body temperature in mice: A quantitative measure of alcohol tolerance and physical dependence. J. Pharmacol. Exp. Ther. 199: 158-163, 1976.
40. A and NMDA receptor function in the rat brain. Alcohol. Clin. Exp. Res. 17: 115-123, 1993.
41. SKAPER, S. D. AND LEON, A.: Monosialogangliosides, neuroprotection, and neuronal repair processes. J. Neurotrauma 9: S507-S516, 1992.
42. SNELL, L. D., IORIO, K. R., TABAKOFF, B. AND HOFFMAN, P. L.: Protein kinase C activation attenuates N-methyl-d-aspartate induced increases in intracellular calcium in cerebellar granule cells. J. Neurochem. 62: 1783-1789, 1994.
43. SNELL, L. D., NUNLEY, K. R., LICKTEIG, R. L., BROWNING, M. D., TABAKOFF, B. AND HOFFMAN, P. L.: Regional and subunit specific changes in NMDA receptor mRNA and immunoreactivity in mouse brain following chronic ethanol ingestion. Mol. Brain Res. 40: 71-78, 1996.
44. SNELL, L. D., TABAKOFF, B. AND HOFFMAN, P. L.: Radioligand binding to the N-methyl-d-aspartate receptor/ionophore complex: Alterations by ethanol in vitro and by chronic in vivo ethanol ingestion. Brain Res. 602: 91-98, 1993.
45. SVENNERHOLM, L.: Gangliosides and synaptic transmission. In Structure and Function of Gangliosides, ed. by L. Svennerholm, P. Mandel, H. Dreyfus and P. F. Urban, pp. 533-544, Plenum Press, New York, 1980.
46. TABAKOFF, B., ANDERSON, R. A. AND RITZMANN, R. F.: Brain acetaldehyde after ethanol administration. Biochem. Pharmacol. 25: 1305-1309, 1976.
47. TABAKOFF, B. AND HOFFMAN, P. L.: Alcohol: Neurobiology. In Substance Abuse: A Comprehensive Textbook, ed. by J. H. Lowinson, P. Ruiz, R. B. Millman and J. G. Langrod, pp. 152-184, Williams & Wilkins, Baltimore, 1992.
48. TABAKOFF, B. AND RITZMANN, R. F.: The effects of 6-hydroxydopamine on tolerance to and dependence on ethanol. J. Pharmacol. Exp. Ther. 203: 319-331, 1977.
49. TABAKOFF, B. AND ROTHSTEIN, J. D.: Biology of Tolerance and Dependence. In Medical and Social Aspects of Alcohol Abuse, ed. by B. Tabakoff, P. B. Sutker and C. L. Randall, pp. 187-220, Plenum Press, New York, 1983.
50. TETTAMANTI, G., VENERANDO, B., ROBERTI, S., CHIGORNO, V., SONNINO, S., GHIDONI, R., ORLANDO, P. AND MASSARI, P.: The fate of exogenously administered brain gangliosides. In Gangliosides in Neurological and Neuromuscular Function, Development, and Repair, ed. by M. M. Rapport and A. Gorio, pp. 225-240, Raven Press, New York, 1981.
51. 3H]MK-801 binding sites following chronic ethanol consumption. Alcohol. Clin. Exp. Res. 18: 1004-1008, 1994.
52. TURSKI, W. A., CAVALHEIRO, E. A., SCHWARCZ, M., CZUCZWAR, S. J., KLEINROK, Z. AND TURSKI, L.: Limbic seizures produced by pilocarpine in rats: Behavioural, electroencephalographic and neuropathological study. Behav. Brain Res. 9: 315-335, 1983.
53. UHUSHIHARA, H., TOHDA, M. AND NOMURA, Y.: Selective potentiation of N-methyl-d-aspartate-induced current by protein kinase C in Xenopus oocytes injected with rat brain RNA. J. Biol. Chem. 267: 11697-11700, 1992.
54. VACCARINO, F. M.: Glutamate receptors, protein kinase C translocation, and gangliosides. Psychopharmacol. Bull. 24: 403-407, 1988.
55. VALVERIUS, P., CRABBE, J. C., HOFFMAN, P. L. AND TABAKOFF, B.: NMDA receptors in mice bred to be prone or resistant to ethanol withdrawal seizures. Eur. J. Pharmacol. 184: 185-189, 1990.
56. WALKER, D. W. AND ZORNETZER, S. F.: Alcohol withdrawal in mice: Electroencephalographic and behavioral correlates. Clin. Neurophysiol. 36: 233-244, 1974.
57. WALLIS, C. J., REZAZADEH, M. AND LAL, H.: GM1 ganglioside reduces ethanol intoxication and the development of ethanol dependence. Alcohol 12: 573-580, 1995.
58. WHITTINGTON, M. A., LAMBERT, J. D. AND LITTLE, H. J.: Increased NMDA receptor and calcium channel activity underlying ethanol withdrawal hyperexcitability. Alcohol Alcohol. 30: 105-114, 1995.
59. WHITTINGTON, M. A. AND LITTLE, H. J.: Nitrendipine, given during drinking, decreases the electrophysiological changes in the isolated hippocampal slice, seen during ethanol withdrawal. Br. J. Pharmacol. 103: 1677-1684, 1991.